Case-reporting of acute hepatitis B and C among injection drug users
- 46 Downloads
Although public health surveillance system data are widely used to describe the epidemiology of communicable disease, occurrence of hepatitis B and C virus (HBV and HCV, respectively) infections may be misrepresented by under-reporting in injection drug users (IDUs). This study was carried out to examine the relationship between HBV and HCV incidence and case-reporting of hepatitis B and C in Seattle IDUs. Names of participants in a Seattle IDU cohort study who acquired HBV or HCV infection over a 12-month follow-up period were compared to a database of persons with acute bepatitis B and C reported to the bealth department surveillance unit over the same period. Of 2,208 IDUs enrolled in the cohort who completed a follow-up visit, 63/759 acquired HBV infection, 53/317 acquired HCV infection, and 3 subjects acquired both HBV and HCV. Of 113 cohort subjects who acquired HBV or HCV, only 2 (1.5%) cases were reported; both bad acute bepatitis B. The upper 95% confidence limit for case-reporting of bepatitis C in the cohort was 5.7%, and for hepatitis B, it was 7.5%. In this study, reporting of acute bepatitis in IDUs was extremely low, raising questions regarding the use of community surveillance data to estimate underlying incidence in that population group.
KeywordsHepatitis B Hepatitis C Substance use Surveillance
Unable to display preview. Download preview PDF.
- 3.Chamot E, de Saussure P, Hirschel B, et al. Incidence of hepatitis C, hepatitis B, and HIV infections among drug users in a methadone maintenance programme. AIDS. 1992; 6:431–432.Google Scholar
- 9.Heptonstall J. Strategies to ensure delivery of hepatitis B vaccine to injecting drug users. Commun Dis Public Health. 1999;2:174–177.Google Scholar
- 10.Margolis HS, Alter MJ, Hadler SC. Viral hepatitis. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans—Epidemiology and Control. New York: Plenum; 1997:363–418.Google Scholar
- 11.Robinson WS. Hepatitis B virus and hepatitis D virus. In: Mandel GE, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 5th ed. Philadelphia, PA: Churchill Livingstone; 2000:1652–1685.Google Scholar
- 13.Chang G, Kosten TR. Detoxification. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, Eds. Substance Abuse: a Comprebensive Textbook. Baltimore, MD: Williams and Wilkins; 1997:377–381.Google Scholar
- 14.Hagan H, Thiede H, McGough JP, Alexander ER. Hepatitis B vaccination among research participants, Seattle, Washington. Am J Public Health. November 2002. In press.Google Scholar
- 15.Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle exchange. J Urban Health. 2000;3:365–378.Google Scholar
- 19.Washington State Department of Health. Annual Communicable Disease Report. Olympia, WA: Washington State Department of Social and Health Services; 1998.Google Scholar
- 20.Centers for Disease Control and Prevention. Summary of notifiable diseases, 1998. MMWR Morb Mortal Wkly Rep. 1999;47:4–7.Google Scholar